| Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS | npj genomic medicine |  | | 2023 | 107 | 41 |
|
| La maturation cérébrale chez les jeunes et la transition des patients consultants en pédopsychiatrie: y-a-t-il une incohérence? | Cahiers de psychologie clinique | | | 2021 | 306 | 1,665 |
|
| Impact de la pandémie de Covid-19 sur les troubles psychiques des adolescents et jeunes adultes | Revue médicale suisse | | | 2021 | 16 | 65 |
|
| Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome | Nature Medicine |  | | 2020 | 359 | 0 |
|
| Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects | American Journal of Human Genetics | | | 2020 | 436 | 0 |
|
| Associations between schizotypal personality features, mentalizing difficulties and thought problems in a sample of community adolescents | Early Intervention in Psychiatry | | | 2020 | 397 | 376 |
|
| Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome | Neuropharmacology |  | | 2020 | 507 | 3 |
|
| Pituitary dysmaturation affects psychopathology and neurodevelopment in 22q11.2 Deletion Syndrome | Psychoneuroendocrinology | | | 2020 | 446 | 624 |
|
| Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion | Molecular Psychiatry | | | 2020 | 428 | 3 |
|
| 22q11 microdeletion syndrome and ultra-high risk for psychosis: The role of neurological soft signs as an independent marker of vulnerability for psychosis | Early Intervention in Psychiatry | | | 2019 | 338 | 1 |
|
| Antipsychotics do not influence neurological soft signs in children and adolescents at ultra-high risk for psychosis: a pilot study | Journal of psychiatric practice | | | 2019 | 314 | 1 |
|
| Prevalence of Non-Affective Psychoses in Individuals with Autism Spectrum Disorders: A Systematic Review | Journal of Clinical Medicine | | | 2019 | 351 | 348 |
|
| Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome | Schizophrenia Research | | | 2019 | 383 | 169 |
|
| Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome | Schizophrenia Research | | | 2019 | 539 | 478 |
|
| Individualized prediction of transition to psychosis in 1,676 individuals at clinical high risk: development and validation of a multivariable prediction model based on individual patient data meta-analysis | Frontiers in Psychiatry | | | 2019 | 332 | 299 |
|
| A Mentalization-Informed Staging Approach to Clinical High Risk for Psychosis | Frontiers in Psychiatry | | | 2019 | 382 | 421 |
|
| Prevalence and Clinical Significance of Symptoms at Ultra High Risk for Psychosis in Children and Adolescents with Obsessive⁻Compulsive Disorder: Is There an Association with Global, Role, and Social Functioning? | Brain Sciences | | | 2018 | 597 | 283 |
|
| Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome | Schizophrenia Bulletin | | | 2018 | 565 | 5 |
|
| Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects | American Journal of Medical Genetics. A | | | 2018 | 406 | 321 |
|
| Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis | Psychological Medicine | | | 2018 | 610 | 228 |
|
| Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome | American Journal of Medical Genetics. A | | | 2018 | 484 | 1 |
|
| Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment | Nature Communications | | | 2018 | 536 | 212 |
|
| Adolescence is the starting point of sex-dichotomous COMT genetic effects | Translational Psychiatry | | | 2017 | 488 | 260 |
|
| Clinical presentation of Attenuated Psychosis Syndrome in children and adolescents: Is there an age effect? | Psychiatry Research | | | 2017 | 446 | 2 |
|
| No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients | Translational Psychiatry | | | 2017 | 633 | 226 |
|
| Détection et traitement précoce des sujets à haut risque clinique depsychose : définitions et recommandations | L'encéphale | | | 2017 | 706 | 13 |
|
| The contribution of a neurodevelopment and genetic perspective to our understanding of the pathogenesis of psychotic disorders: the case of 22q11ds and of youth populations | | | | 2017 | 486 | 7 |
|
| Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study | Schizophrenia bulletin | | | 2017 | 568 | 0 |
|
| No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis? | PLOS ONE | | | 2017 | 546 | 309 |
|
| Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome | World Psychiatry | | | 2016 | 511 | 0 |
|
| Cognitive Decline Preceding the Onset of Psychosis in Patients With 22q11.2 Deletion Syndrome | JAMA psychiatry | | | 2015 | 703 | 1,288 |
|
| Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome | The American journal of psychiatry | | | 2014 | 998 | 8 |
|
| Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes | American journal of human genetics | | | 2013 | 713 | 3 |
|
